Valuation: Incyte Corporation

Market Cap 25.87B 22.56B 21.3B 19.34B 36.24B 2,482B 36.39B 255B 98.45B 1,262B 97.17B 95.02B 4,061B P/E 2026 *
57x
P/E 2027 * 17.6x
Enterprise Value 21.64B 18.87B 17.82B 16.18B 30.31B 2,076B 30.44B 213B 82.36B 1,056B 81.29B 79.48B 3,397B EV / Sales 2026 *
3.64x
EV / Sales 2027 * 3.17x
Free-Float
98.14%
Yield 2026 *
-
Yield 2027 * -
1 day-0.52%
1 week+5.00%
Current month+3.51%
1 month+3.30%
3 months+29.85%
6 months+38.27%
Current year+29.13%
1 week 119.97
Extreme 119.97
128.72
1 month 119.97
Extreme 119.97
130.8
Current year 89.25
Extreme 89.25
132.6
1 year 81.09
Extreme 81.09
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
25/8/26 Tax

EVP, Human Resources

-504 0.0002%
19/8/26 Sell

Chairperson

-10,801 0.0053%
12/8/26 Sell

Chairperson

-10,803 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%+5.00%+48.30%+114.32% 25.87B
-0.66%+0.42%+31.08%-4.81% 78.83B
-1.11%+3.59%-12.67%-34.40% 60.48B
-1.76%+8.28%+512.53%+49.69% 63.11B
+0.14%-1.76%-10.86%+24.38% 46.75B
-0.24%+1.22%+2.26%+151.03% 45.66B
-0.94%-0.08%+50.88%-14.34% 32.37B
+0.47%+2.38%+0.10%+146.43% 21.33B
+0.27%+1.96%+62.19%+102.81% 15.8B
-1.63%-8.52%+24.26%+132.20% 13.16B
Average -0.61%+2.34%+70.81%+66.73% 40.33B
Weighted average by Cap. -0.72%+3.57%+93.78%+43.87%

Financials

2026 *2027 *
Net sales 5.94B 5.18B 4.89B 4.44B 8.32B 570B 8.36B 58.6B 22.62B 290B 22.32B 21.83B 933B 6.27B 5.46B 5.16B 4.68B 8.78B 601B 8.81B 61.79B 23.84B 306B 23.53B 23.01B 983B
Net income 466M 406M 384M 348M 653M 44.7B 655M 4.59B 1.77B 22.73B 1.75B 1.71B 73.12B 1.5B 1.3B 1.23B 1.12B 2.1B 144B 2.1B 14.75B 5.69B 72.98B 5.62B 5.49B 235B
Net Debt -4.23B -3.69B -3.48B -3.16B -5.93B -406B -5.95B -41.72B -16.1B -206B -15.89B -15.54B -664B -5.99B -5.22B -4.93B -4.48B -8.39B -575B -8.43B -59.09B -22.8B -292B -22.5B -22.01B -940B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
19/09/26 USD 127.14 -0.38% 541,950
17/09/26 USD 127.62 +2.30% 1,468,843
16/09/26 USD 124.75 +2.47% 1,347,302
15/09/26 USD 121.74 -0.37% 1,564,077
14/09/26 USD 122.19 +0.59% 1,455,967
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
127.62USD
Average target price
127.74USD
Spread / Average Target
+0.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!